Viridian Therapeutics, Inc. company logo
Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc. (VRDN) Cash From Operations

Annual CFO

-$232.32M$48.15M-26.14%

Summary

Current Value
As of today, VRDN annual cash from operations is -$232.32M, down -26.14% on
Historical Performance
VRDN annual cash from operations is down -325.64% over the past 3 years, and down -544.33% over the past 5 years
All-Time High Comparison
VRDN annual cash from operations is currently -19790.33% below its historical high of -$1.17M set on
3-Year Low Comparison
VRDN annual cash from operations is at its 3-year low
Sector Comparison
VRDN annual cash from operations is higher than 3.39% of companies in Healthcare sector

Cash From Operations Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

VRDN Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Operations-$232.32M-26.1%-325.6%-544.3%-3632.2%
Quarterly Cash From Operations-$84.61M-25.0%-1560.7%
TTM Cash From Operations-$325.97M-65.5%-1058.0%
Price$30.57+46.2%+11.3%+66.1%
Annual Cash From Investing-$228.65M-142.6%-207.8%-910.1%-10000.0%
Annual Cash From Financing$457.74M+102.8%+265.4%+10000.0%+7784.4%
Annual Free Cash Flow-$232.83M-25.8%-323.9%-544.2%-3577.2%
Annual CAPEX$511.00K-43.1%+51.2%+508.3%+378.0%
Annual Net Income-$208.56M+12.3%-162.6%-398.1%-3612.2%

Cash From Operations Highs

VRDN Annual Cash From Operations Highs Comparison
PeriodHighDateCurrent
3Y-$93.84MN/A-147.6%
5Y-$29.78MN/A-680.1%
All-$1.17M>-9999.0%

Cash From Operations Lows

VRDN Annual Cash From Operations Lows Comparison
PeriodLowDateCurrent
3Y-$232.32Mat low
5Y-$232.32Mat low
All-$232.32Mat low

Cash From Operations History

YearValueChange
-$232.32M-26.1%
-$184.17M-96.3%
-$93.84M-71.9%
-$54.58M-83.3%
-$29.78M+17.4%
-$36.06M-34.3%
YearValueChange
-$26.84M+4.7%
-$28.17M-289.5%
-$7.23M-4.8%
-$6.90M-211.7%
-$2.21M-

FAQ

  • What is the current annual cash from operations of VRDN?

    As of today, VRDN annual cash from operations is -$232.32M

  • What is 1-year change in VRDN annual cash from operations?

    VRDN annual cash from operations is down -26.14% year-over-year

  • What is 3-year change in VRDN annual cash from operations?

    VRDN annual cash from operations is down -325.64% over the past 3 years

  • How far is VRDN annual cash from operations from its all-time high?

    VRDN annual cash from operations is currently -19790.33% below its historical high of -$1.17M set on December 31, 2013

  • How does VRDN annual cash from operations rank versus sector peers?

    VRDN annual cash from operations is higher than 3.39% of companies in Healthcare sector

  • When is VRDN next annual earnings release?

    The next annual earnings release for VRDN is on

Cash From Operations Formula

CFO = + Non Cash Expenses + Changes In

Data Sources & References

  1. VRDN Official Website www.viridiantherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1590750/000159075025000020/0001590750-25-000020-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1590750/000159075025000004/0001590750-25-000004-index.htm
  4. VRDN Profile on Yahoo Finance finance.yahoo.com/quote/VRDN
  5. VRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrdn